These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26193946)

  • 1. Generic Selection Criteria for Safety and Patient Benefit [IV] - Physicochemical and pharmaceutical properties of brand-name and generic ketoprofen tapes.
    Wada Y; Kihara M; Nozawa M; Shimokawa K; Ishii F
    Drug Discov Ther; 2015 Jun; 9(3):229-33. PubMed ID: 26193946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generic selection criteria for safety and patient benefit [X]: Water-vapor permeability and peel force properties of brand-name and generic ketoprofen tapes.
    Nozawa M; Goto M; Wada Y; Ishii F; Shimokawa KI
    Drug Discov Ther; 2021 May; 15(2):87-92. PubMed ID: 33952778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic selection criteria for safety and patient benefit [VIII]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic diclofenac sodium tapes.
    Nozawa M; Goto M; Wada Y; Yotsukura K; Gannichida A; Ishii F; Shimokawa KI
    Drug Discov Ther; 2019 Jul; 13(3):150-156. PubMed ID: 31257355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prediction of systemic exposure of ketoprofen tapes by in vitro release test and pharmacokinetic model analysis: comparison between brand-name and generic formulations].
    Awa K; Satoh H; Hori S; Sawada Y
    Yakugaku Zasshi; 2012; 132(1):135-44. PubMed ID: 22214588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic selection criteria for safety and patient benefit [VI]: Comparing the physicochemical and pharmaceutical properties of brand-name, generic, and OTC felbinac tapes.
    Wada Y; Takaoka Y; Nozawa M; Goto M; Shimokawa KI; Ishii F
    Drug Discov Ther; 2017 Jan; 10(6):300-306. PubMed ID: 27725574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic selection criteria for safety and patient benefit [VII]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic terbinafine hydrochloride cream.
    Nozawa M; Goto M; Wada Y; Kumazawa M; Shimokawa KI; Ishii F
    Drug Discov Ther; 2018 Mar; 12(1):16-20. PubMed ID: 29479048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Questionnaire survey of patients comparing the usability of brand-name and generic ketoprofen tapes].
    Saita A; Inoue A; Ishibashi H; Tominaga K; Hori S; Miki A; Ohtani H; Ono N; Sawada Y
    Yakugaku Zasshi; 2008 May; 128(5):795-803. PubMed ID: 18451628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic selection criteria for safety and patient benefit [XI]: Usability scores of brand-name and generic tapes containing sodium diclofenac by questionnaire survey.
    Nozawa M; Gannichida A; Wada Y; Kumazawa M; Ishii F; Shimokawa KI
    Drug Discov Ther; 2022 Nov; 16(5):210-216. PubMed ID: 36261340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria for the selection of switch OTC drugs based on patient benefits, efficacy, and safety [II]: Comparing the physicochemical and pharmaceutical properties of brand-name and switch OTC terbinafine hydrochloride cream.
    Takata M; Wada Y; Iwasawa Y; Kumazawa M; Shimokawa KI; Ishii F
    Drug Discov Ther; 2018; 12(4):248-253. PubMed ID: 30224597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic selection criteria for safety and patient benefit [Ⅻ]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic tulobuterol tape.
    Shimokawa KI; Yotsukura K; Nozawa M; Wada Y; Ishii F
    Drug Discov Ther; 2024 Jan; 17(6):409-414. PubMed ID: 38044119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic selection criteria for safety and patient benefit [V]: Comparing the pharmaceutical properties and patient usability of original and generic nasal spray containing ketotifen fumarate.
    Wada Y; Ami S; Nozawa M; Goto M; Shimokawa K; Ishii F
    Drug Discov Ther; 2016; 10(2):88-92. PubMed ID: 27210891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Questionnaire survey on the change of asthmatic response, adverse events and product usability due to drug switching between name-brand and generic tulobuterol tapes].
    Izumi T; Hori S; Satoh H; Miki A; Sawada Y
    Yakugaku Zasshi; 2012; 132(5):617-27. PubMed ID: 22687698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular State of Active Pharmaceutical Ingredients in Ketoprofen Dermal Patches Characterized by Pharmaceutical Evaluation.
    Azuma M; Fujii M; Inoue M; Hisada H; Koide T; Kemper M; Yamamoto Y; Suzuki N; Suzuki T; Fukami T
    Biol Pharm Bull; 2018; 41(9):1348-1354. PubMed ID: 30175772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Bioequivalence Between Brand-name and Generic Irinotecan Products.
    Saito KI; Inoue Y; Ikegami Y; Nanbo I; Onozuka M; Sano K; Yoshida H; Sakamoto T; Tatebayashi E; Fujita KI; Sasaki Y; Kitazawa T
    Anticancer Res; 2016 Nov; 36(11):5957-5963. PubMed ID: 27793921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication persistence and the use of generic and brand-name blood pressure-lowering agents.
    Corrao G; Soranna D; La Vecchia C; Catapano A; Agabiti-Rosei E; Gensini G; Merlino L; Mancia G
    J Hypertens; 2014 May; 32(5):1146-53; discussion 1153. PubMed ID: 24569417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the efficacy of topical corticosteroid: five locally made and one brand name creams.
    Puavilai S; Krisadaphong P; Leenutaphong V; Asawanonda P; Akaraphan R; Ploysangham T; Ruangkarnchanasetr S; Noppakun N; Charuwichitratana S; Kulthanan K; Huiprasert P; Tresukosol P; Ophaswongse S
    J Med Assoc Thai; 2002 Jul; 85(7):789-99. PubMed ID: 12296411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Converting patients from brand-name clozapine to generic clozapine.
    Sajbel TA; Carter GW; Wiley RB
    Ann Pharmacother; 2001 Mar; 35(3):281-4. PubMed ID: 11261523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Adhesives on the Properties of Adhesion, Drug Release and Skin Permeation of Lidocaine Tapes].
    Sugino M; Mikami M; Ishihara T; Hosoya O; Juni K
    Yakugaku Zasshi; 2015; 135(8):977-85. PubMed ID: 26234356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency of brand name and generic levothyroxine.
    Stoffer SS; Szpunar WE
    JAMA; 1980 Oct; 244(15):1704-5. PubMed ID: 7411829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.